Nuvation Bio is trading 5.06% down at $4.88 on October 5, 2026; no clear company-specific announcement explaining the decline was found.
- The company’s investor news page lists September 17 as its latest news item, with no October 5 announcement.
- The S&P 500 and Nasdaq were higher while the Dow was lower; available evidence does not point to a clear market-wide cause.
- A news search found no reliable report directly tying a catalyst to the intraday decline.